NRx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.18	1.44	4.6	20.05	27.61	1.86
Cash & Short-Term Investments	7.18	1.44	4.6	20.05	27.61	1.86
Cash Growth	336.45%	-68.60%	-77.09%	-27.35%	1384.94%	111.87%
Other Receivables	3.09	-	0.01	0.01	-	0.83
Receivables	3.33	-	0.01	0.01	-	0.83
Prepaid Expenses	1.44	1.04	1.41	3.77	4.6	0.21
Other Current Assets	-	0.82	0.87	1.97	0.51	0.03
Total Current Assets	11.95	3.3	6.88	25.8	32.71	2.93
Other Long-Term Assets	0.24	0.35	0.43	0.02	0.02	0.01
Total Assets	15	3.65	7.32	25.82	32.73	2.94
Accounts Payable	4.26	4.13	4.63	2.08	3.69	3.15
Accrued Expenses	5.47	6.13	5.24	5.77	2.84	3.28
Current Portion of Long-Term Debt	9.91	1.25	9.16	7.7	0.52	0.25
Other Current Liabilities	20.77	10.35	0.02	0.04	4.87	39.49
Total Current Liabilities	40.59	21.86	19.05	15.59	11.92	46.16
Long-Term Debt	-	5.01	-	2.82	-	0.55
Total Liabilities	40.75	26.87	19.05	18.41	11.92	46.71
Common Stock	0.03	0.02	0.01	0.07	0.06	0.04
Additional Paid-In Capital	281.47	255.04	241.41	230.34	203.99	46.37
Retained Earnings	-307.26	-278.27	-253.15	-223	-183.24	-90.18
Comprehensive Income & Other	-	-	-0	-	-	-
Total Common Equity	-25.76	-23.22	-11.74	7.41	20.81	-43.77
Shareholders' Equity	-25.76	-23.22	-11.73	7.41	20.81	-43.77
Total Liabilities & Equity	15	3.65	7.32	25.82	32.73	2.94
Total Debt	10.26	6.26	9.16	10.53	0.52	0.8
Net Cash (Debt)	-3.07	-4.81	-4.57	9.53	27.09	1.06
Net Cash Growth	-	-	-	-64.82%	2450.57%	-
Net Cash Per Share	-0.18	-0.45	-0.60	1.45	5.77	0.31
Filing Date Shares Outstanding	28.1	16.92	9.45	7.06	6.66	11.83
Total Common Shares Outstanding	27.68	14.59	8.27	6.54	5.88	11.23
Working Capital	-28.65	-18.56	-12.16	10.21	20.79	-43.23
Book Value Per Share	-0.93	-1.59	-1.42	1.13	3.54	-3.90
Tangible Book Value	-28.14	-23.22	-11.74	7.41	20.81	-43.77
Tangible Book Value Per Share	-1.02	-1.59	-1.42	1.13	3.54	-3.90

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q